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Abstract
Background: Congenital complete heart block is a life-threatening condition which is highly associated with
autoimmune and connective tissue disorders. Presence of maternal autoantibodies for associated conditions increases the
risk of delivering a child with congenital complete heart block, however, less than a half of all women with such
antibodies are symptomatic even after delivery. Mortality rate is highest during the neonatal period (45 %) and about
two-thirds of all cases will require permanent pacing at some point in their lives.
Case presentation: We report a case of isolated complete heart block in a 5-year-old HIV-free girl of African descent
born to an HIV-infected woman with no prior history of autoimmune disorders. She was referred to us with chief
complaints of recurrent syncopal attacks and effort intolerance since birth. A physical examination was unremarkable
except for her being small for her age (body mass index 16.3 kg/m2) and bradycardia. Her vital signs were within
acceptable range with the exception of her pulse rate, which ranged between 22 and 34 beats/minute. An
echocardiogram revealed a sinus bradycardia, otherwise a structurally normal heart. An electrocardiogram showed
atrioventricular dissociation in keeping with third-degree atrioventricular block. The child underwent a permanent
epicardial pacemaker insertion and has been symptom-free following pacing.
Conclusions: Despite its infrequency and life-threatening potential, patients with congenital complete heart block have
an excellent survival rate with timely diagnosis and intervention. An incidental detection of bradycardia in a fetus during
routine obstetrical ultrasound examination should increase the index of suspicion for congenital complete heart block
and warrant a screening for associated maternal autoantibodies.
Keywords: Congenital complete heart block, Congenital third-degree AV block, Isolated congenital heart block, Recurrent
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Background
Congenital complete heart block (CCHB) is a rare, perman-
ent, irreversible and life-threatening anomaly that is present
in about 1 of every 20,000 live-born infants [1]. It may be
diagnosed in utero, during infanthood or early childhood
and is frequently associated with maternal autoantibodies,
or rarely with a congenital structural deformity of the heart
[2]. The risk of delivering a child with CCHB is higher
among women who are anti-SSA/Ro or anti-SSB/La posi-
tive and in those with autoimmune hypothyroidism [3].
The transplacental transfer of maternal autoantibodies to
SSA/Ro or SSB/La ribonucleoproteins may lead to inflam-
mation and ultimately fibrosis of the fetal conduction sys-
tem [4]. Interestingly, over 50 % of mothers carrying such
autoantibodies are asymptomatic and are identified only
after they have children with a heart block [4]. Furthermore,
the risk of CCHB recurrence among women with associ-
ated autoantibodies rises to 17 % in the second offspring
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and may rise up to 50 % in subsequent deliveries [4]. For
instance, infants with neonatal lupus erythromatosus (NLE)
have up to a 30 % risk of developing CCHB compared to
infants without it and such infants comprise over 90 % of
all CCHB cases [5, 6].
Clinically, CCHB presents with recurrent fainting attacks,
a slow pulse rate and electrocardiographic (ECG) findings
in keeping with complete heart block [1, 2, 4]. About two-
thirds of all CCHB cases will require permanent pacing,
which provides an excellent prognosis especially among
those with the isolated form [7]. Overall mortality rate in
CCHB is about 20 %, it is higher in utero (27 %) or during
early infancy (45 %) and is associated with delayed pacing
therapy [7, 8]. Comparatively, CCHB cases with comorbid
cardiac structural malformations have the worst prognosis
[2]. We report a case of isolated complete heart block in a
5-year-old girl with a history of recurrent syncopal attacks
and effort intolerance since birth.
Case presentation
A 5-year-old HIV-free girl of African descent was referred
to us with chief complaints of recurrent syncopal attacks
and effort intolerance since birth. She is a third-born child
to a 38-year-old, single, HIV-infected woman. Her mother
first gave birth at the age of 27, she was HIV-free then but
the baby was born with spina bifida and anencephaly and
survived for just a few hours after birth. She then gave birth
to a baby girl 2 years later; the child is healthy and alive
until today. She became pregnant again 4 years after the
birth of her second child. During an antenatal clinic visit
for this pregnancy, she tested negative for hepatitis B and
her syphilis screening was nonreactive. She was never
screened for rubella or autoimmune conditions. She had
low hemoglobin concentration throughout (9.4–10.9 g/dL),
but received hematenics, antihelminthics, antimalarial and
tetanus toxoid immunization as per protocol. She was di-
agnosed with HIV infection during the antenatal clinic
visit at 24 weeks’ gestation and was started on antiretro-
viral medication. She reported that she took the medica-
tion for 3 days only and decided to stop because she did
not want her family to know of her HIV serostatus. She
had severe hyperemesis gravidarum during her first
trimester and was hospitalized seven times due to this.
Her pregnancy thereafter was uneventful and she gave
birth to a full-term baby girl weighing 2.3 kilograms
who scored 7/10 on the APGAR scale. The child was
given nevirapine at birth and she was instructed to con-
tinue giving it for 6 weeks, but for the same reasons she
stopped her child’s nevirapine on the third day. She
exclusively breastfed her child for 6 months and never
resumed her or her child’s antiretroviral medication during
this period. The mother denied any symptoms suggestive of
hypothyroidism, connective tissue or autoimmune disor-
ders before, during, and after pregnancy.
During her third child’s first few weeks of life, the
mother observed that she was breastfeeding poorly and
was sleeping for longer duration compared to her sister
at her age. At about 8 weeks, it was observed that the
child would go into an unarousable state on exertion
or while breastfeeding. This state lasted between 30
minutes and 1 hour, and upon regaining consciousness,
the child was lethargic. The child never presented with
a crying episode or convulsions prior to her loss of
consciousness. The child was taken to a health facility
and the mother was told that her child’s heart was
beating slower than usual but was assured that it would
go away with time. She continued to present with syn-
copal attacks until the age of 2 years but was never ad-
mitted for this or any other illness and had normal
developmental milestones. She was free of such epi-
sodes for about 3 years, however, she was mostly leth-
argic with a decreased effort capacity, had a poor
weight gain and was generally inactive for her age.
Three weeks prior to this index admission, she pre-
sented again with episodes of loss of consciousness
which persisted until she came to our attention. She
had experienced between three and five episodes per
day, each lasting for about an hour and after regaining
consciousness she slept for up to 12 hours. This time
round, minor activities including swallowing and rising
from a lying position led to syncope. Since birth, the
child had never had features of heart failure or a transi-
ent rash suggestive of neonatal lupus erythromatosus.
Furthermore, the mother denies any prescription of
steroids for herself or her child between pregnancy and
now.
Upon admission to our institute, the child underwent
a thorough physical examination and a series of investi-
gations. The physical examination was unremarkable
except for her being small for her age (body mass index
(BMI) 16.3 kg/m2) and bradycardia. Her vital signs
were within acceptable range with the exception of her
pulse rate, which ranged between 22 and 34 beats/mi-
nute. She had normal electrolytes, renal and liver func-
tion, full blood count and random blood sugar test
results. Serology results for HIV and hepatitis (B and C)
were negative. An echocardiogram revealed a sinus
bradycardia, otherwise a structurally normal heart. An
ECG showed AV dissociation in keeping with third-
degree atrioventricular (AV) block, Fig. 1. Anti-SSA/Ro
and anti-SSB/La antibodies tests are unavailable in the
country and were not screened for, however, the mother
tested negative for anti-double-stranded deoxyribo-
nucleic acid (dsDNA), antinuclear antibodies (ANA)
and antineutrophil cytoplasmic antibodies (ANCA)
autoantibodies. The child underwent a permanent epi-
cardial pacemaker insertion and has been symptom-
free following pacing.
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Discussion
Complete congenital heart block is a potentially fatal
condition although in this modern era the prognosis is
excellent. In the developed world, the majority of pa-
tients are diagnosed in utero, however, in resource-
limited settings where fetal echocardiography is a rare
practice, diagnosis is exclusively made during infancy
[9]. Early diagnosis of isolated CCHB, which is highly as-
sociated with autoimmune disorders, remains a chal-
lenge even in the best centers because the majority of
women are asymptomatic even after delivery [1, 4, 5, 8].
When CCHB is diagnosed in utero in a woman with
autoantibodies, several therapeutic approaches including
use of steroids, sympathomimetics, plasmapheresis, and
fetal pacing have been implicated [10]. Children with
CCHB exhibiting symptoms early in life are regarded
high risk and necessitate urgent pacing. A pacemaker
aims to prevent sudden cardiac death, provide symptom-
atic relief, and improve the quality of life [2].
In the case presented, the child was symptomatic from
birth but a definitive diagnosis of CCHB was made at
around the age of 5. While mortality rate due to CCHB
is reportedly high during the neonatal period, our case is
very fortunate to have survived until age 5 without any
intervention despite the presence of recurrent syncopal
attacks since birth. This case, despite undergoing all the
diagnostic hurdles, served as a learning platform to prac-
titioners in our center as this was the first-ever case of
CCHB to be diagnosed, paced, and documented in
Tanzania.
Conclusions
In conclusion, despite of its infrequency and life-
threatening potential, patients with CCHB have an excellent
survival rate with timely diagnosis and intervention. Fur-
thermore, among women with established associated auto-
immune conditions, frequent echocardiographic fetal heart
rate assessment and necessary in utero interventions are
essential for better fetal outcomes. On the other hand,
incidental detection of bradycardia in a fetus during routine
obstetrical ultrasound examination should increase an
index of suspicion for CCHB and warrant a screening for
associated maternal autoantibodies.
Abbreviations
ANA: Antinuclear antibodies; ANCA: Antineutrophil cytoplasmic
antibodies; AV: Atrioventricular; CCHB: Complete congenital heart block;
dsDNA: Double-stranded deoxyribonucleic acid; ECG: Electrocardiogram;
NLE: Neonatal lupus erythromatosus
Acknowledgements
The authors are grateful to the pediatricians and surgeons from the Jakaya
Kikwete Cardiac Institute. Furthermore, the authors are indebted to the
pediatric department of the Muhimbili National Hospital for their continual
cooperation in improving children’s health.
Funding
Not applicable.
Availability of data and material
Not applicable.
Authors’ contributions
PP and IM took the history and performed the physical examination. NM
performed the echocardiography. GS performed the pacemaker insertion.
PP wrote the initial draft of the manuscript. All authors reviewed and
Fig. 1 Electrocardiogram showing atrioventricular dissociation in keeping with the diagnosis of complete heart block
Pallangyo et al. Journal of Medical Case Reports  (2016) 10:288 Page 3 of 4
contributed to the final version of this case report. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient’s legal guardians
for publication of this case report and any accompanying images. A copy of
the written consent is available for review by the Editor-in-Chief of this
journal.
Ethics approval and consent to participate
Ethical clearance was sought from the Directorate of Research of the Jakaya
Kikwete Cardiac Institute.
Author details
1Department of Cardiovascular Medicine, The Jakaya Kikwete Cardiac
Institute, P.O Box 65141, Dar es Salaam, Tanzania. 2Department of Pediatric
and Child Health, Muhimbili National Hospital, P.O Box 65000, Dar es Salaam,
Tanzania. 3Department of Pediatric Cardiology, The Jakaya Kikwete Cardiac
Institute, P.O Box 65141, Dar es Salaam, Tanzania.
Received: 15 August 2016 Accepted: 29 September 2016
References
1. Massa AC, Freitas I, Borges A, Serrano F. Congenital complete atrioventricular
block – case report and review of the literature. Acta Obstet Ginecol
Port. 2015;9(4):318–21.
2. Kiblawi M, Naeem A, Al Attrash E, Kar S, Goud BK. Complete congenital
heart block in a newborn associated with maternal systemic lupus
erythematosus: a case report. Int J Med Students. 2013;1(3):128–31.
3. Hon KL, Leung AK. Neonatal lupus erythematosus. Autoimmune Dis.
2012;2012:301274.
4. Yildirim A, Tunaodlu FS, Karaadac AT. Neonatal congenital heart block.
Indian Pediatr. 2013;50(5):483–8.
5. Izmirly PM, Saxena A, Kim MY, Wang D, Sahl SK, Llanos C, et al.
Maternal and fetal factors associated with mortality and morbidity in a
multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal
lupus. Circulation. 2011;124(18):1927–35.
6. Rein AJJT, Mevorach D, Perles Z, et al. Early diagnosis and treatment of
atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La
antibodies: a prospective, observational, fetal kinetocardiogram–based
study. Circulation. 2009;119:1867–72.
7. Moak JP, Barron KS, Hougen TJ, et al. Congenital heart block: development
of late-onset cardiomyopathy, a previously underappreciated sequela. JACC.
2001;37(1):238–42.
8. Eronen M, Siren MK, Ekblad H, et al. Short-and long-term outcome of
children with congenital complete heart block diagnosed in utero or as a
newborn. Pediatrics. 2000;106:86–91.
9. Waltuck J, Buyon JP. Autoantibody associated complete heart block:
outcome in mothers and children. Ann Intern Med. 1994;120:544–51.
10. Buyon JP, Waltuck J, Kleinman C, Copel J. In utero identification and therapy
of congenital heart block. Lupus. 1995;4(2):116–21.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Pallangyo et al. Journal of Medical Case Reports  (2016) 10:288 Page 4 of 4
